The Peripheral Artery Disease Global Market Report 2023, provides comprehensive information on the peripheral artery disease market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.
Learn More On The Peripheral Artery Disease Market’s Growth:
https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report
The global peripheral artery disease market size is expected to grow from $3.67 billion in 2022 to $3.97 billion in 2023 at a compound annual growth rate (CAGR) of 8.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The size of peripheral artery disease market is expected to reach $5.27 billion in 2027 at a CAGR of 7.3%
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=12068&type=smp
Technological advancements are a key trend gaining popularity in the peripheral artery disease market. Major companies operating in the peripheral artery disease market are adopting technologically advanced surgery treatments to sustain their position in the market. For instance, in November 2022, Genesis MedTech Group, a Singapore-based medical device company, introduced chocolate touch paclitaxel DCB catheter, a percutaneous transluminal angioplasty (PTA) catheter for the treatment of patients with superficial femoral artery and popliteal artery disease. The Chocolate Touch drug-coated balloon is the first and only balloon catheter in the device that combines therapeutic agent administration with a next-generation angioplasty platform for treating peripheral artery disease. It uses pillow-like structures covered with a therapeutic chemical to open in tiny parts to offer an alternate therapy to standard drug-coated balloon angioplasty for individuals suffering from peripheral artery disease. As a result, the balloon surface increases, allowing for more effective medication delivery to the vessel wall and eliminating the requirement for permanent implants.
The peripheral artery disease market is segmented:
1) By Type: Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Peripheral Accessories
2) By Drugs: Lipid-Lowering Drugs, Blood Pressure Lowering Drugs, Glucose Regulating Drugs, Blood Clot Preventing Drugs, Inotropes, Thrombolytics Agents, Anti-Inflammatory Agents
3) By Route of Administration: Oral, Parenteral, Other Routes of Administration
4) By End Users: Hospitals, Specialty Clinics, Other End Users
North America was the largest region in the peripheral artery disease market in 2022.
The table of contents in TBRC’s peripheral artery disease market report includes:
1. Executive Summary
2. Peripheral Artery Disease Market Characteristics
3. Peripheral Artery Disease Market Trends And Strategies
5. Peripheral Artery Disease Market Segmentation
.
.
.
26. South America Peripheral Artery Disease Market
27. Brazil Peripheral Artery Disease Market
28. Middle East Peripheral Artery Disease Market
29. Africa Peripheral Artery Disease Market
30. Peripheral Artery Disease Market Competitive Landscape And Company Profiles
Top Major Players:
- Cardinal Health Inc
- Vascular Solutions Inc.
- Bayer AG
- Abbott Laboratories
- Medtronic plc
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
